Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays

Jeremiah H. Li, Chase A. Mazur, Tomaz Berisa, Joseph K. Pickrell
doi: https://doi.org/10.1101/2020.04.29.068452
Jeremiah H. Li
1Gencove, Inc. New York, NY 10016
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jeremy.li@gencove.com
Chase A. Mazur
1Gencove, Inc. New York, NY 10016
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomaz Berisa
1Gencove, Inc. New York, NY 10016
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph K. Pickrell
1Gencove, Inc. New York, NY 10016
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Low-pass sequencing (sequencing a genome to an average depth less than 1x coverage) combined with genotype imputation has been proposed as an alternative to genotyping arrays for trait mapping and calculation of polygenic scores; however, the current literature is largely limited to simulation- and downsampling-based approaches. To empirically assess the relative performance of these technologies for different applications, we performed low-pass sequencing (targeting coverage levels of 0.5x and 1x) and array genotyping (using the Illumina Global Screening Array) on 120 DNA samples derived from African and European-ancestry individuals that are part of the 1000 Genomes Project. We then imputed both the sequencing data and the genotyping array data to the 1000 Genomes Phase 3 haplotype reference panel using a leave-one-out design. First, we evaluated overall imputation accuracy from these different assays as measured by genotype concordance; we introduce the concept of effective coverage that accounts for evenness of sequencing and show that this metric is a better predictor of imputation accuracy than nominal mapped coverage for low-pass sequencing data. Next, we evaluated overall power for genome-wide association studies (GWAS) as measured by the squared correlation between imputed and true genotypes. In the African individuals, at common variants (> 5% minor allele frequency), imputation r2 averaged 0.83 for the array data and ranged from 0.89 to 0.95 for the low-pass sequencing data, corresponding to an effective 7 – 15% increase in GWAS discovery power. For the same variants in the European individuals, imputation r2 averaged 0.91 for the array data and ranged from 0.92-0.96 for the low-pass sequencing data, corresponding to an effective 1-6% increase in GWAS discovery power. Finally, we computed polygenic risk scores for breast cancer and coronary artery disease from the different assays. We observed consistently lower measurement error for risk scores computed from low-pass sequencing data above an effective coverage of ∼ 0.5x. The mean squared error of the array-based estimates was three to four times that of the estimates from samples sequenced at an effective coverage of ∼ 1.2x for coronary artery disease, with qualitatively similar results for breast cancer. We conclude that low-pass sequencing plus imputation, in addition to providing a substantial increase in statistical power for genome wide association studies, provides increased accuracy for polygenic risk prediction at effective coverages of ∼ 0.5x and higher.

Competing Interest Statement

J.H.L., C.A.M., T.B., and J.K.P. were employees of Gencove, Inc. at the time of writing.

Footnotes

  • Several typos fixed; note added to indicate availability of loimpute.

  • https://gencove-sbir.s3.amazonaws.com/index.html

  • https://gitlab.com/gencove/loimpute-public

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays
Jeremiah H. Li, Chase A. Mazur, Tomaz Berisa, Joseph K. Pickrell
bioRxiv 2020.04.29.068452; doi: https://doi.org/10.1101/2020.04.29.068452
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays
Jeremiah H. Li, Chase A. Mazur, Tomaz Berisa, Joseph K. Pickrell
bioRxiv 2020.04.29.068452; doi: https://doi.org/10.1101/2020.04.29.068452

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genomics
Subject Areas
All Articles
  • Animal Behavior and Cognition (3497)
  • Biochemistry (7341)
  • Bioengineering (5318)
  • Bioinformatics (20249)
  • Biophysics (10000)
  • Cancer Biology (7734)
  • Cell Biology (11291)
  • Clinical Trials (138)
  • Developmental Biology (6431)
  • Ecology (9943)
  • Epidemiology (2065)
  • Evolutionary Biology (13312)
  • Genetics (9358)
  • Genomics (12575)
  • Immunology (7696)
  • Microbiology (18999)
  • Molecular Biology (7432)
  • Neuroscience (40972)
  • Paleontology (300)
  • Pathology (1228)
  • Pharmacology and Toxicology (2133)
  • Physiology (3155)
  • Plant Biology (6857)
  • Scientific Communication and Education (1272)
  • Synthetic Biology (1895)
  • Systems Biology (5309)
  • Zoology (1087)